Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries - healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Analyst Ratings Changes
A number of research analysts recently issued reports on the stock. Morgan Stanley dropped their price objective on shares of Ventas from $59.00 to $52.00 and set an "equal weight" rating for the company in a report on Friday, July 15th. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of Ventas from $67.00 to $65.00 and set a "buy" rating for the company in a report on Wednesday, July 13th. StockNews.com upgraded shares of Ventas from a "sell" rating to a "hold" rating in a report on Monday, August 8th. Credit Suisse Group assumed coverage on shares of Ventas in a report on Wednesday, June 22nd. They set an "outperform" rating and a $63.00 price target for the company. Finally, Jefferies Financial Group upgraded shares of Ventas from a "hold" rating to a "buy" rating and raised their price target for the stock from $58.00 to $59.00 in a report on Thursday, June 30th. Three analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $61.80.
Ventas Stock Down 0.6 %
NYSE:VTR traded down $0.30 during trading hours on Friday, hitting $48.72. 27,157 shares of the company traded hands, compared to its average volume of 1,729,238. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 1.16. The firm's 50-day simple moving average is $51.00 and its 200-day simple moving average is $54.80. Ventas has a one year low of $45.44 and a one year high of $64.02. The company has a market cap of $19.47 billion, a PE ratio of 980.20, a PEG ratio of 3.22 and a beta of 1.12.
Ventas Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Thursday, July 14th. Shareholders of record on Friday, July 1st were paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 3.69%. The ex-dividend date of this dividend was Thursday, June 30th. Ventas's dividend payout ratio (DPR) is presently 3,600.72%.
Insider Transactions at Ventas
In other news, CEO Debra A. Cafaro sold 17,400 shares of the stock in a transaction that occurred on Wednesday, June 1st. The shares were sold at an average price of $56.43, for a total transaction of $981,882.00. Following the completion of the transaction, the chief executive officer now directly owns 767,960 shares of the company's stock, valued at approximately $43,335,982.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 1.30% of the company's stock.